FHIR CI-Build

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions icon

4.4.1.270 ValueSet http://hl7.org/fhir/ValueSet/vaccine-code

Public Health icon Work Group  Maturity Level: 1 Draft Use Context: Country: World
Official URL: http://hl7.org/fhir/ValueSet/vaccine-code Version: 6.0.0-ballot3
active as of 2025-10-13 Computable Name: VaccineAdministeredValueSet
Flags: OID: 2.16.840.1.113883.3.88.12.80.22

This value set is used in the following places:

4.4.1.270.1 Definition

This identifies the vaccine substance administered - CVX codes.

4.4.1.270.2 Content Logical Definition

Generated Narrative: ValueSet vaccine-code

Last updated: 2025-10-13T17:52:05.807Z

Profile: Shareable ValueSet

This value set includes codes based on the following rules:

  • Include all codes defined in http://hl7.org/fhir/sid/cvx icon version Not Stated (use latest from terminology server)
  • Include all codes defined in urn:oid:1.2.36.1.2001.1005.17 version Not Stated (use latest from terminology server)

 

4.4.1.270.3 Expansion

This expansion generated 13 Oct 2025

ValueSet

Expansion from tx.fhir.org based on codesystem Vaccine Administered Code Set (CVX) version 20250715

This value set contains 360 concepts

SystemCodeDisplayDisplay (English)
http://hl7.org/fhir/sid/cvx   01 DTP diphtheria, tetanus toxoids and pertussis vaccine
http://hl7.org/fhir/sid/cvx   02 OPV, trivalent trivalent poliovirus vaccine, live, oral
http://hl7.org/fhir/sid/cvx   03 MMR measles, mumps and rubella virus vaccine
http://hl7.org/fhir/sid/cvx   04 M/R measles and rubella virus vaccine
http://hl7.org/fhir/sid/cvx   05 measles measles virus vaccine
http://hl7.org/fhir/sid/cvx   06 rubella rubella virus vaccine
http://hl7.org/fhir/sid/cvx   07 mumps mumps virus vaccine
http://hl7.org/fhir/sid/cvx   08 Hep B, adolescent or pediatric hepatitis B vaccine, pediatric or pediatric/adolescent dosage
http://hl7.org/fhir/sid/cvx   09 Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
http://hl7.org/fhir/sid/cvx   10 IPV poliovirus vaccine, inactivated
http://hl7.org/fhir/sid/cvx   11 pertussis pertussis vaccine
http://hl7.org/fhir/sid/cvx   12 diphtheria antitoxin diphtheria antitoxin
http://hl7.org/fhir/sid/cvx   13 TIG tetanus immune globulin
http://hl7.org/fhir/sid/cvx   14 IG, unspecified formulation immune globulin, unspecified formulation
http://hl7.org/fhir/sid/cvx   15 influenza, split (incl. purified surface antigen) influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE
http://hl7.org/fhir/sid/cvx   16 influenza, whole influenza virus vaccine, whole virus
http://hl7.org/fhir/sid/cvx   17 Hib, unspecified formulation Haemophilus influenzae type b vaccine, conjugate unspecified formulation
http://hl7.org/fhir/sid/cvx   18 rabies, intramuscular injection rabies vaccine, for intramuscular injection RETIRED CODE
http://hl7.org/fhir/sid/cvx   19 BCG Bacillus Calmette-Guerin vaccine
http://hl7.org/fhir/sid/cvx   20 DTaP diphtheria, tetanus toxoids and acellular pertussis vaccine
http://hl7.org/fhir/sid/cvx   21 varicella varicella virus vaccine
http://hl7.org/fhir/sid/cvx   22 DTP-Hib DTP-Haemophilus influenzae type b conjugate vaccine
http://hl7.org/fhir/sid/cvx   23 plague plague vaccine
http://hl7.org/fhir/sid/cvx   24 Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis
http://hl7.org/fhir/sid/cvx   25 typhoid, oral typhoid vaccine, live, oral
http://hl7.org/fhir/sid/cvx   26 cholera, unspecified formulation cholera vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   27 botulinum antitoxin botulinum antitoxin
http://hl7.org/fhir/sid/cvx   28 DT (pediatric) diphtheria and tetanus toxoids, adsorbed for pediatric use
http://hl7.org/fhir/sid/cvx   29 CMVIG cytomegalovirus immune globulin, intravenous
http://hl7.org/fhir/sid/cvx   30 HBIG hepatitis B immune globulin
http://hl7.org/fhir/sid/cvx   31 Hep A, pediatric, unspecified formulation hepatitis A vaccine, pediatric dosage, unspecified formulation
http://hl7.org/fhir/sid/cvx   32 meningococcal MPSV4 meningococcal polysaccharide vaccine (MPSV4)
http://hl7.org/fhir/sid/cvx   33 pneumococcal polysaccharide PPV23 pneumococcal polysaccharide vaccine, 23 valent
http://hl7.org/fhir/sid/cvx   34 RIG rabies immune globulin
http://hl7.org/fhir/sid/cvx   35 tetanus toxoid, adsorbed tetanus toxoid, adsorbed
http://hl7.org/fhir/sid/cvx   36 VZIG varicella zoster immune globulin
http://hl7.org/fhir/sid/cvx   37 yellow fever live yellow fever vaccine live
http://hl7.org/fhir/sid/cvx   38 rubella/mumps rubella and mumps virus vaccine
http://hl7.org/fhir/sid/cvx   39 Japanese encephalitis SC Japanese Encephalitis Vaccine SC
http://hl7.org/fhir/sid/cvx   40 rabies, intradermal injection rabies vaccine, for intradermal injection
http://hl7.org/fhir/sid/cvx   41 typhoid, parenteral typhoid vaccine, parenteral, other than acetone-killed, dried
http://hl7.org/fhir/sid/cvx   42 Hep B, adolescent/high risk infant hepatitis B vaccine, adolescent/high risk infant dosage
http://hl7.org/fhir/sid/cvx   43 Hep B, adult hepatitis B vaccine, adult dosage
http://hl7.org/fhir/sid/cvx   44 Hep B, high-dosage, dialysis or IC Hepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient
http://hl7.org/fhir/sid/cvx   45 Hep B, unspecified formulation hepatitis B vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   46 Hib (PRP-D) Haemophilus influenzae type b vaccine, PRP-D conjugate
http://hl7.org/fhir/sid/cvx   47 Hib (HbOC) Haemophilus influenzae type b vaccine, HbOC conjugate
http://hl7.org/fhir/sid/cvx   48 Hib (PRP-T) Haemophilus influenzae type b vaccine, PRP-T conjugate
http://hl7.org/fhir/sid/cvx   49 Hib (PRP-OMP) Haemophilus influenzae type b vaccine, PRP-OMP conjugate
http://hl7.org/fhir/sid/cvx   50 DTaP-Hib DTaP-Haemophilus influenzae type b conjugate vaccine
http://hl7.org/fhir/sid/cvx   51 Hib-Hep B Haemophilus influenzae type b conjugate and Hepatitis B vaccine
http://hl7.org/fhir/sid/cvx   52 Hep A, adult hepatitis A vaccine, adult dosage
http://hl7.org/fhir/sid/cvx   53 typhoid, parenteral, AKD (U.S. military) typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)
http://hl7.org/fhir/sid/cvx   54 adenovirus, type 4 adenovirus vaccine, type 4, live, oral
http://hl7.org/fhir/sid/cvx   55 adenovirus, type 7 adenovirus vaccine, type 7, live, oral
http://hl7.org/fhir/sid/cvx   56 dengue fever tetravalent dengue fever vaccine, tetravalent
http://hl7.org/fhir/sid/cvx   57 hantavirus hantavirus vaccine
http://hl7.org/fhir/sid/cvx   58 Hep C hepatitis C vaccine
http://hl7.org/fhir/sid/cvx   59 Hep E hepatitis E vaccine
http://hl7.org/fhir/sid/cvx   60 herpes simplex 2 herpes simplex virus, type 2 vaccine
http://hl7.org/fhir/sid/cvx   61 HIV human immunodeficiency virus vaccine
http://hl7.org/fhir/sid/cvx   62 HPV, quadrivalent human papilloma virus vaccine, quadrivalent
http://hl7.org/fhir/sid/cvx   63 Junin virus Junin virus vaccine
http://hl7.org/fhir/sid/cvx   64 leishmaniasis leishmaniasis vaccine
http://hl7.org/fhir/sid/cvx   65 leprosy leprosy vaccine
http://hl7.org/fhir/sid/cvx   66 Lyme disease Lyme disease vaccine
http://hl7.org/fhir/sid/cvx   67 malaria malaria vaccine
http://hl7.org/fhir/sid/cvx   68 melanoma melanoma vaccine
http://hl7.org/fhir/sid/cvx   69 parainfluenza-3 parainfluenza-3 virus vaccine
http://hl7.org/fhir/sid/cvx   70 Q fever Q fever vaccine
http://hl7.org/fhir/sid/cvx   71 RSV-IGIV respiratory syncytial virus immune globulin, intravenous
http://hl7.org/fhir/sid/cvx   72 rheumatic fever rheumatic fever vaccine
http://hl7.org/fhir/sid/cvx   73 Rift Valley fever Rift Valley fever vaccine
http://hl7.org/fhir/sid/cvx   74 rotavirus, tetravalent rotavirus, live, tetravalent vaccine
http://hl7.org/fhir/sid/cvx   75 Vaccinia (smallpox, mpox), live Vaccinia (smallpox, mpox) vaccine, live
http://hl7.org/fhir/sid/cvx   76 Staphylococcus bacterio lysate Staphylococcus bacteriophage lysate
http://hl7.org/fhir/sid/cvx   77 Tick-borne encephalitis vaccine (non-US) Tick-borne encephalitis vaccine (non-US)
http://hl7.org/fhir/sid/cvx   78 tularemia vaccine tularemia vaccine
http://hl7.org/fhir/sid/cvx   79 vaccinia immune globulin vaccinia immune globulin
http://hl7.org/fhir/sid/cvx   80 VEE, live Venezuelan equine encephalitis, live, attenuated
http://hl7.org/fhir/sid/cvx   81 VEE, inactivated Venezuelan equine encephalitis, inactivated
http://hl7.org/fhir/sid/cvx   82 adenovirus, unspecified formulation adenovirus vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   83 Hep A, ped/adol, 2 dose hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule
http://hl7.org/fhir/sid/cvx   84 Hep A, ped/adol, 3 dose hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule
http://hl7.org/fhir/sid/cvx   85 Hep A, unspecified formulation hepatitis A vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   86 IG immune globulin, intramuscular
http://hl7.org/fhir/sid/cvx   87 IGIV immune globulin, intravenous
http://hl7.org/fhir/sid/cvx   88 influenza, unspecified formulation influenza virus vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   89 polio, unspecified formulation poliovirus vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   90 rabies, unspecified formulation rabies vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   91 typhoid, unspecified formulation typhoid vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   92 VEE, unspecified formulation Venezuelan equine encephalitis vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   93 RSV-MAb respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular
http://hl7.org/fhir/sid/cvx   94 MMRV measles, mumps, rubella, and varicella virus vaccine
http://hl7.org/fhir/sid/cvx   95 TST-OT tine test tuberculin skin test; old tuberculin, multipuncture device
http://hl7.org/fhir/sid/cvx   96 TST-PPD intradermal tuberculin skin test; purified protein derivative solution, intradermal
http://hl7.org/fhir/sid/cvx   97 TST-PPD tine test tuberculin skin test; purified protein derivative, multipuncture device
http://hl7.org/fhir/sid/cvx   98 TST, unspecified formulation tuberculin skin test; unspecified formulation
http://hl7.org/fhir/sid/cvx   99 RESERVED - do not use RESERVED - do not use
http://hl7.org/fhir/sid/cvx   100 pneumococcal conjugate PCV 7 pneumococcal conjugate vaccine, 7 valent
http://hl7.org/fhir/sid/cvx   101 typhoid, ViCPs typhoid Vi capsular polysaccharide vaccine
http://hl7.org/fhir/sid/cvx   102 DTP-Hib-Hep B DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine
http://hl7.org/fhir/sid/cvx   103 meningococcal C conjugate meningococcal C conjugate vaccine
http://hl7.org/fhir/sid/cvx   104 Hep A-Hep B hepatitis A and hepatitis B vaccine
http://hl7.org/fhir/sid/cvx   105 vaccinia (smallpox) diluted vaccinia (smallpox) vaccine, diluted
http://hl7.org/fhir/sid/cvx   106 DTaP, 5 pertussis antigens diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens
http://hl7.org/fhir/sid/cvx   107 DTaP, unspecified formulation diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   108 meningococcal ACWY, unspecified formulation meningococcal ACWY vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   109 pneumococcal, unspecified formulation pneumococcal vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   110 DTaP-Hep B-IPV DTaP-hepatitis B and poliovirus vaccine
http://hl7.org/fhir/sid/cvx   111 Influenza, live, trivalent, intranasal, PF Influenza, live, trivalent, intranasal, preservative free
http://hl7.org/fhir/sid/cvx   112 tetanus toxoid, unspecified formulation tetanus toxoid, unspecified formulation
http://hl7.org/fhir/sid/cvx   113 Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
http://hl7.org/fhir/sid/cvx   114 meningococcal MCV4P meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)
http://hl7.org/fhir/sid/cvx   115 Tdap tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed
http://hl7.org/fhir/sid/cvx   116 rotavirus, pentavalent rotavirus, live, pentavalent vaccine
http://hl7.org/fhir/sid/cvx   117 VZIG (IND) varicella zoster immune globulin (Investigational New Drug)
http://hl7.org/fhir/sid/cvx   118 HPV, bivalent human papilloma virus vaccine, bivalent
http://hl7.org/fhir/sid/cvx   119 rotavirus, monovalent rotavirus, live, monovalent vaccine
http://hl7.org/fhir/sid/cvx   120 DTaP-Hib-IPV diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
http://hl7.org/fhir/sid/cvx   121 zoster live zoster vaccine, live
http://hl7.org/fhir/sid/cvx   122 rotavirus, unspecified formulation rotavirus vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   123 influenza, H5N1-1203 influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)
http://hl7.org/fhir/sid/cvx   125 Novel Influenza-H1N1-09, nasal Novel Influenza-H1N1-09, live virus for nasal administration
http://hl7.org/fhir/sid/cvx   126 Novel influenza-H1N1-09, preservative-free Novel influenza-H1N1-09, preservative-free, injectable
http://hl7.org/fhir/sid/cvx   127 Novel influenza-H1N1-09 Novel influenza-H1N1-09, injectable
http://hl7.org/fhir/sid/cvx   128 Novel Influenza-H1N1-09, all formulations Novel influenza-H1N1-09, all formulations
http://hl7.org/fhir/sid/cvx   129 Japanese Encephalitis, unspecified formulation Japanese Encephalitis vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   130 DTaP-IPV Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated
http://hl7.org/fhir/sid/cvx   131 typhus, historical Historical record of a typhus vaccination
http://hl7.org/fhir/sid/cvx   132 DTaP-IPV-HIB-HEP B, historical Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.
http://hl7.org/fhir/sid/cvx   133 Pneumococcal conjugate PCV 13 pneumococcal conjugate vaccine, 13 valent
http://hl7.org/fhir/sid/cvx   134 Japanese Encephalitis IM Japanese Encephalitis vaccine for intramuscular administration
http://hl7.org/fhir/sid/cvx   135 Influenza, high-dose, trivalent, PF Influenza, high-dose, split virus, trivalent, injectable, preservative free
http://hl7.org/fhir/sid/cvx   136 Meningococcal MCV4O meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)
http://hl7.org/fhir/sid/cvx   137 HPV, unspecified formulation HPV, unspecified formulation
http://hl7.org/fhir/sid/cvx   138 Td (adult) tetanus and diphtheria toxoids, not adsorbed, for adult use
http://hl7.org/fhir/sid/cvx   139 Td(adult) unspecified formulation Td(adult) unspecified formulation
http://hl7.org/fhir/sid/cvx   140 Influenza, split virus, trivalent, PF Influenza, split virus, trivalent, injectable, preservative free
http://hl7.org/fhir/sid/cvx   141 Influenza, split virus, trivalent, preservative Influenza, split virus, trivalent, injectable, contains preservative
http://hl7.org/fhir/sid/cvx   142 tetanus toxoid, not adsorbed tetanus toxoid, not adsorbed
http://hl7.org/fhir/sid/cvx   143 Adenovirus types 4 and 7 Adenovirus, type 4 and type 7, live, oral
http://hl7.org/fhir/sid/cvx   144 influenza, seasonal, intradermal, preservative free seasonal influenza, intradermal, preservative free
http://hl7.org/fhir/sid/cvx   145 RSV-MAb (new) respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular
http://hl7.org/fhir/sid/cvx   146 DTaP,IPV,Hib,HepB Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.
http://hl7.org/fhir/sid/cvx   147 meningococcal MCV4, unspecified formulation Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)
http://hl7.org/fhir/sid/cvx   148 Meningococcal C/Y-HIB PRP Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
http://hl7.org/fhir/sid/cvx   149 Influenza, live, quadrivalent, intranasal Influenza, live, quadrivalent, intranasal
http://hl7.org/fhir/sid/cvx   150 Influenza, split virus, quadrivalent, PF Influenza, split virus, quadrivalent, injectable, preservative free
http://hl7.org/fhir/sid/cvx   151 influenza nasal, unspecified formulation influenza nasal, unspecified formulation
http://hl7.org/fhir/sid/cvx   152 Pneumococcal Conjugate, unspecified formulation Pneumococcal Conjugate, unspecified formulation
http://hl7.org/fhir/sid/cvx   153 Influenza, MDCK, trivalent, PF Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free
http://hl7.org/fhir/sid/cvx   154 Hep A, IG Hepatitis A immune globulin
http://hl7.org/fhir/sid/cvx   155 Influenza, recombinant, trivalent, PF Influenza, recombinant, trivalent, injectable, preservative free
http://hl7.org/fhir/sid/cvx   156 Rho(D)-IG Rho(D) Immune globulin- IV or IM
http://hl7.org/fhir/sid/cvx   157 Rho(D) -IG IM Rho(D) Immune globulin - IM
http://hl7.org/fhir/sid/cvx   158 Influenza, split virus, quadrivalent, preservative Influenza, split virus, quadrivalent, injectable, contains preservative
http://hl7.org/fhir/sid/cvx   159 Rho(D) - Unspecified formulation Rho(D) Unspecified formulation
http://hl7.org/fhir/sid/cvx   160 Influenza A monovalent (H5N1), ADJUVANTED-2013 Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013
http://hl7.org/fhir/sid/cvx   161 Influenza, injectable,quadrivalent, preservative free, pediatric Influenza, injectable,quadrivalent, preservative free, pediatric
http://hl7.org/fhir/sid/cvx   162 meningococcal B, recombinant meningococcal B vaccine, fully recombinant
http://hl7.org/fhir/sid/cvx   163 meningococcal B, OMV meningococcal B vaccine, recombinant, OMV, adjuvanted
http://hl7.org/fhir/sid/cvx   164 meningococcal B, unspecified meningococcal B, unspecified formulation
http://hl7.org/fhir/sid/cvx   165 HPV9 Human Papillomavirus 9-valent vaccine
http://hl7.org/fhir/sid/cvx   166 influenza, intradermal, quadrivalent, preservative free influenza, intradermal, quadrivalent, preservative free, injectable
http://hl7.org/fhir/sid/cvx   167 meningococcal, unknown serogroups meningococcal vaccine of unknown formulation and unknown serogroups
http://hl7.org/fhir/sid/cvx   168 Influenza, adjuvanted, trivalent, PF Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free
http://hl7.org/fhir/sid/cvx   169 Hep A, live attenuated Hep A, live attenuated-IM
http://hl7.org/fhir/sid/cvx   170 DTAP/IPV/HIB - non-US non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
http://hl7.org/fhir/sid/cvx   171 Influenza, MDCK, quadrivalent, PF Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free
http://hl7.org/fhir/sid/cvx   172 cholera, WC-rBS cholera, WC-rBS
http://hl7.org/fhir/sid/cvx   173 cholera, BivWC cholera, BivWC
http://hl7.org/fhir/sid/cvx   174 cholera, live attenuated cholera, live attenuated
http://hl7.org/fhir/sid/cvx   175 Rabies - IM Diploid cell culture Human Rabies vaccine from human diploid cell culture
http://hl7.org/fhir/sid/cvx   176 Rabies - IM fibroblast culture Human rabies vaccine from Chicken fibroblast culture
http://hl7.org/fhir/sid/cvx   177 PCV10 pneumococcal conjugate vaccine, 10 valent
http://hl7.org/fhir/sid/cvx   178 OPV bivalent Non-US bivalent oral polio vaccine (types 1 and 3)
http://hl7.org/fhir/sid/cvx   179 OPV ,monovalent, unspecified Non-US monovalent oral polio vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   180 tetanus immune globulin tetanus immune globulin
http://hl7.org/fhir/sid/cvx   181 anthrax immune globulin anthrax immune globulin
http://hl7.org/fhir/sid/cvx   182 OPV, Unspecified Oral Polio Vaccine, Unspecified formulation
http://hl7.org/fhir/sid/cvx   183 Yellow fever vaccine live - alt Yellow fever vaccine live - alternative formulation for vaccine shortage
http://hl7.org/fhir/sid/cvx   184 Yellow fever, unspecified Yellow fever vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   185 Influenza, recombinant, quadrivalent, PF Influenza, recombinant, quadrivalent, injectable, preservative free
http://hl7.org/fhir/sid/cvx   186 Influenza, MDCK, quadrivalent, preservative Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative
http://hl7.org/fhir/sid/cvx   187 zoster recombinant zoster vaccine recombinant
http://hl7.org/fhir/sid/cvx   188 zoster, unspecified formulation zoster vaccine, unspecified formulation
http://hl7.org/fhir/sid/cvx   189 HepB-CpG Hepatitis B vaccine (recombinant), CpG adjuvanted
http://hl7.org/fhir/sid/cvx   190 Typhoid conjugate vaccine (TCV) Typhoid conjugate vaccine (non-US)
http://hl7.org/fhir/sid/cvx   191 meningococcal A polysaccharide (non-US) meningococcal A polysaccharide vaccine (non-US)
http://hl7.org/fhir/sid/cvx   192 meningococcal AC polysaccharide (non-US) meningococcal AC polysaccharide vaccine (non-US)
http://hl7.org/fhir/sid/cvx   193 Hep A-Hep B, pediatric/adolescent hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)
http://hl7.org/fhir/sid/cvx   194 Influenza, Southern Hemisphere influenza, Southern Hemisphere, unspecified formulation
http://hl7.org/fhir/sid/cvx   195 DT, IPV adsorbed Diphtheria, Tetanus, Poliomyelitis adsorbed
http://hl7.org/fhir/sid/cvx   196 Td, adsorbed, preservative free, adult use, Lf unspecified tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified
http://hl7.org/fhir/sid/cvx   197 Influenza, high-dose, quadrivalent, PF Influenza, high-dose, split virus, quadrivalent, injectable, preservative free
http://hl7.org/fhir/sid/cvx   198 DTP-hepB-Hib Pentavalent Non-US Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)
http://hl7.org/fhir/sid/cvx   200 influenza, Southern Hemisphere, pediatric, preservative free influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free
http://hl7.org/fhir/sid/cvx   201 Influenza, Southern Hemisphere, quadrivalent, PF Influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5 mL dose, preservative free
http://hl7.org/fhir/sid/cvx   202 influenza, Southern Hemisphere, quadrivalent, with preservative influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative
http://hl7.org/fhir/sid/cvx   203 meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free
http://hl7.org/fhir/sid/cvx   204 Ebola Zaire vaccine, live, recombinant, 1mL dose Ebola Zaire vaccine, live, recombinant, 1mL dose
http://hl7.org/fhir/sid/cvx   205 Influenza, adjuvanted, quadrivalent, PF Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free
http://hl7.org/fhir/sid/cvx   206 Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection
http://hl7.org/fhir/sid/cvx   207 COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
http://hl7.org/fhir/sid/cvx   208 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose
http://hl7.org/fhir/sid/cvx   210 COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL
http://hl7.org/fhir/sid/cvx   211 COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose
http://hl7.org/fhir/sid/cvx   212 COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL
http://hl7.org/fhir/sid/cvx   213 SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
http://hl7.org/fhir/sid/cvx   214 Ebola, unspecified Ebola, unspecified
http://hl7.org/fhir/sid/cvx   215 Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free
http://hl7.org/fhir/sid/cvx   216 Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free
http://hl7.org/fhir/sid/cvx   217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation
http://hl7.org/fhir/sid/cvx   218 COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation
http://hl7.org/fhir/sid/cvx   219 COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation
http://hl7.org/fhir/sid/cvx   220 HepB recombinant, 3-antigen, Al(OH)3 Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted
http://hl7.org/fhir/sid/cvx   221 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose
http://hl7.org/fhir/sid/cvx   222 Tick-borne encephalitis, unspecified Tick-borne encephalitis vaccine, unspecified
http://hl7.org/fhir/sid/cvx   223 Tick-borne encephalitis, inactivated, PF, 0.25mL Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose
http://hl7.org/fhir/sid/cvx   224 Tick-borne encephalitis, inactivated, PF, 0.5mL Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose
http://hl7.org/fhir/sid/cvx   225 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose
http://hl7.org/fhir/sid/cvx   226 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose
http://hl7.org/fhir/sid/cvx   227 COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose
http://hl7.org/fhir/sid/cvx   228 COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose
http://hl7.org/fhir/sid/cvx   229 COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose
http://hl7.org/fhir/sid/cvx   230 COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose
http://hl7.org/fhir/sid/cvx   231 influenza, Southern Hemisphere, high-dose, quadrivalent influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free
http://hl7.org/fhir/sid/cvx   300 COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation
http://hl7.org/fhir/sid/cvx   301 COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation
http://hl7.org/fhir/sid/cvx   302 COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation
http://hl7.org/fhir/sid/cvx   303 RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free
http://hl7.org/fhir/sid/cvx   304 Respiratory syncytial virus (RSV), unspecified Respiratory syncytial virus (RSV), unspecified
http://hl7.org/fhir/sid/cvx   305 RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free
http://hl7.org/fhir/sid/cvx   306 RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 0.5 mL, neonates and children to 24 months
http://hl7.org/fhir/sid/cvx   307 RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 1 mL, neonates and children to 24 months
http://hl7.org/fhir/sid/cvx   308 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose
http://hl7.org/fhir/sid/cvx   309 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose
http://hl7.org/fhir/sid/cvx   310 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose
http://hl7.org/fhir/sid/cvx   311 COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose
http://hl7.org/fhir/sid/cvx   312 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose
http://hl7.org/fhir/sid/cvx   313 COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose
http://hl7.org/fhir/sid/cvx   314 Respiratory syncytial virus (RSV) vaccine, unspecified Respiratory syncytial virus (RSV) vaccine, unspecified
http://hl7.org/fhir/sid/cvx   315 Respiratory syncytial virus (RSV) MAB, unspecified Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified
http://hl7.org/fhir/sid/cvx   316 Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free
http://hl7.org/fhir/sid/cvx   317 Chikungunya live attenuated vaccine, 0.5 mL, PF Chikungunya, live attenuated vaccine, 0.5 mL, preservative free
http://hl7.org/fhir/sid/cvx   318 Anthrax, post-exposure prophylaxis Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis
http://hl7.org/fhir/sid/cvx   319 Anthrax vaccine, unspecified Anthrax vaccine, unspecified
http://hl7.org/fhir/sid/cvx   320 Influenza, MDCK, trivalent, preservative Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative
http://hl7.org/fhir/sid/cvx   321 Influenza-avian, H5N8, monovalent, PF Influenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free
http://hl7.org/fhir/sid/cvx   322 Influenza-avian, H5N8, monovalent, preservative Influenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative
http://hl7.org/fhir/sid/cvx   323 Influenza-avian, H5, unspecified formulation Influenza-avian, H5, unspecified formulation
http://hl7.org/fhir/sid/cvx   324 Poliovirus, inactivated, fractional-dose (fIPV) Poliovirus, inactivated, fractional-dose (fIPV)
http://hl7.org/fhir/sid/cvx   325 Vaccinia (smallpox, mpox), unspecified Vaccinia (smallpox, mpox), unspecified
http://hl7.org/fhir/sid/cvx   326 RSV, mRNA, injectable, PF Respiratory syncytial virus (RSV), mRNA, injectable, preservative free
http://hl7.org/fhir/sid/cvx   327 Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF Pneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free
http://hl7.org/fhir/sid/cvx   328 Meningococcal oligosaccharide (MenACWY), (MenB), PF Meningococcal oligosaccharide conjugated (groups A, C, W, Y) and group B, 0.5 mL, preservative free
http://hl7.org/fhir/sid/cvx   329 Chikungunya, VLP, recombinant, 0.8 mL, PF Chikungunya, virus-like particle (VLP), recombinant vaccine, 0.8 mL, preservative free
http://hl7.org/fhir/sid/cvx   330 Dengue fever, unspecified Dengue fever, unspecified formulation
http://hl7.org/fhir/sid/cvx   331 Influenza, Southern Hemisphere, trivalent, PF Influenza, seasonal, Southern Hemisphere, trivalent, 0.5 mL dose, preservative free
http://hl7.org/fhir/sid/cvx   332 RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF Respiratory syncytial virus (RSV), monoclonal antibody, IgG1κ , (clesrovimab-cfor), 0.7 mL, neonate and infant, preservative free
http://hl7.org/fhir/sid/cvx   333 Influenza, live, trivalent, intranasal, self/caregiver admin, PF Influenza, live, trivalent, intranasal, self or caregiver administered, preservative free
http://hl7.org/fhir/sid/cvx   500 COVID-19 Non-US Vaccine, Product Unknown SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown
http://hl7.org/fhir/sid/cvx   501 COVID-19 IV Non-US Vaccine (QAZCOVID-IN) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)
http://hl7.org/fhir/sid/cvx   502 COVID-19 IV Non-US Vaccine (COVAXIN) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)
http://hl7.org/fhir/sid/cvx   503 COVID-19 LAV Non-US Vaccine (COVIVAC) SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)
http://hl7.org/fhir/sid/cvx   504 COVID-19 VVnr Non-US Vaccine (Sputnik Light) SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)
http://hl7.org/fhir/sid/cvx   505 COVID-19 VVnr Non-US Vaccine (Sputnik V) SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)
http://hl7.org/fhir/sid/cvx   506 COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology
http://hl7.org/fhir/sid/cvx   507 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)
http://hl7.org/fhir/sid/cvx   508 COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)
http://hl7.org/fhir/sid/cvx   509 COVID-19 PS Non-US Vaccine (EpiVacCorona) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)
http://hl7.org/fhir/sid/cvx   510 COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)
http://hl7.org/fhir/sid/cvx   511 COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)
http://hl7.org/fhir/sid/cvx   512 SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz)
http://hl7.org/fhir/sid/cvx   513 SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax)
http://hl7.org/fhir/sid/cvx   514 SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D)
http://hl7.org/fhir/sid/cvx   515 SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901)
http://hl7.org/fhir/sid/cvx   516 COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
http://hl7.org/fhir/sid/cvx   517 SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax)
http://hl7.org/fhir/sid/cvx   518 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
http://hl7.org/fhir/sid/cvx   519 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
http://hl7.org/fhir/sid/cvx   520 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech
http://hl7.org/fhir/sid/cvx   521 COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK
http://hl7.org/fhir/sid/cvx   801 AS03 Adjuvant AS03 Adjuvant
http://hl7.org/fhir/sid/cvx   998 no vaccine administered no vaccine administered
http://hl7.org/fhir/sid/cvx   999 unknown unknown vaccine or immune globulin
urn:oid:1.2.36.1.2001.1005.17   AGRPAL Agrippal
urn:oid:1.2.36.1.2001.1005.17   AVAXM Avaxim
urn:oid:1.2.36.1.2001.1005.17   BCG BCG
urn:oid:1.2.36.1.2001.1005.17   CDT CDT
urn:oid:1.2.36.1.2001.1005.17   CMX COMVAX
urn:oid:1.2.36.1.2001.1005.17   DTP Triple Antigen
urn:oid:1.2.36.1.2001.1005.17   DTPA DTPa
urn:oid:1.2.36.1.2001.1005.17   ENGP Engerix B
urn:oid:1.2.36.1.2001.1005.17   FLRIX Fluarix
urn:oid:1.2.36.1.2001.1005.17   FLUVAX Fluvax
urn:oid:1.2.36.1.2001.1005.17   FLVRN Fluvirin
urn:oid:1.2.36.1.2001.1005.17   FVXJNR Fluvax Junior
urn:oid:1.2.36.1.2001.1005.17   GNDIP Diphtheria
urn:oid:1.2.36.1.2001.1005.17   GNFLU Influenza
urn:oid:1.2.36.1.2001.1005.17   GNHEP Hepatitis B
urn:oid:1.2.36.1.2001.1005.17   GNHIB HIB
urn:oid:1.2.36.1.2001.1005.17   GNHPA Hepatitis A
urn:oid:1.2.36.1.2001.1005.17   GNJEN Japanese Encephalitis
urn:oid:1.2.36.1.2001.1005.17   GNMEA Measles
urn:oid:1.2.36.1.2001.1005.17   GNMEN Meningococcal C
urn:oid:1.2.36.1.2001.1005.17   GNMUM Mumps
urn:oid:1.2.36.1.2001.1005.17   GNPNE Pneumococcal
urn:oid:1.2.36.1.2001.1005.17   GNPOL Polio
urn:oid:1.2.36.1.2001.1005.17   GNROX Rotavirus
urn:oid:1.2.36.1.2001.1005.17   GNRUB Rubella
urn:oid:1.2.36.1.2001.1005.17   GNTET Tetanus
urn:oid:1.2.36.1.2001.1005.17   GNVAR Varicella
urn:oid:1.2.36.1.2001.1005.17   HATWNJ Twinrix Junior
urn:oid:1.2.36.1.2001.1005.17   HAVAQ Vaqta Paed/Adol
urn:oid:1.2.36.1.2001.1005.17   HAVJ Havrix Junior
urn:oid:1.2.36.1.2001.1005.17   HBOC HibTITER
urn:oid:1.2.36.1.2001.1005.17   HBV HBV
urn:oid:1.2.36.1.2001.1005.17   HBVP HBVAX II
urn:oid:1.2.36.1.2001.1005.17   HBX Hiberix
urn:oid:1.2.36.1.2001.1005.17   IFHX Infanrix Hexa
urn:oid:1.2.36.1.2001.1005.17   IFIP Infanrix-IPV
urn:oid:1.2.36.1.2001.1005.17   IFPA Infanrix Penta
urn:oid:1.2.36.1.2001.1005.17   IFX Infanrix
urn:oid:1.2.36.1.2001.1005.17   IFXB InfanrixHepB
urn:oid:1.2.36.1.2001.1005.17   INFLUV Influvac
urn:oid:1.2.36.1.2001.1005.17   IPV IPOL
urn:oid:1.2.36.1.2001.1005.17   JEVAX JE-VAX
urn:oid:1.2.36.1.2001.1005.17   MENJUG Menjugate
urn:oid:1.2.36.1.2001.1005.17   MENTEC Meningitec
urn:oid:1.2.36.1.2001.1005.17   MENUME Menomune
urn:oid:1.2.36.1.2001.1005.17   MENVAX Mencevax ACWY
urn:oid:1.2.36.1.2001.1005.17   MMR MMR
urn:oid:1.2.36.1.2001.1005.17   MMRCSL MMR II
urn:oid:1.2.36.1.2001.1005.17   MMRSKB Priorix
urn:oid:1.2.36.1.2001.1005.17   MNTRX Menitorix
urn:oid:1.2.36.1.2001.1005.17   NEISVC NeisVac-C
urn:oid:1.2.36.1.2001.1005.17   OPV Polio
urn:oid:1.2.36.1.2001.1005.17   P Pertussis
urn:oid:1.2.36.1.2001.1005.17   PANVAX Panvax
urn:oid:1.2.36.1.2001.1005.17   PDCL Pediacel
urn:oid:1.2.36.1.2001.1005.17   PLCL Poliacel
urn:oid:1.2.36.1.2001.1005.17   PNEUMO Pneumovax
urn:oid:1.2.36.1.2001.1005.17   PRPD ProHIBit
urn:oid:1.2.36.1.2001.1005.17   PROQAD ProQuad
urn:oid:1.2.36.1.2001.1005.17   PRPOMP PedvaxHIB
urn:oid:1.2.36.1.2001.1005.17   PRPT ActHIB
urn:oid:1.2.36.1.2001.1005.17   PRVNR Prevenar 7
urn:oid:1.2.36.1.2001.1005.17   PRVTH Prevenar 13
urn:oid:1.2.36.1.2001.1005.17   PRXTEX Priorix-Tetra
urn:oid:1.2.36.1.2001.1005.17   QDCL Quadracel
urn:oid:1.2.36.1.2001.1005.17   ROTRIX Rotarix
urn:oid:1.2.36.1.2001.1005.17   ROTTEQ Rotateq
urn:oid:1.2.36.1.2001.1005.17   SYNFLX Synflorix
urn:oid:1.2.36.1.2001.1005.17   TCL Tripacel
urn:oid:1.2.36.1.2001.1005.17   VAXGRP Vaxigrip
urn:oid:1.2.36.1.2001.1005.17   VGRJNR Vaxigrip Junior
urn:oid:1.2.36.1.2001.1005.17   VLRIX Varilrix
urn:oid:1.2.36.1.2001.1005.17   VRVAX Varivax

 

See the full registry of value sets defined as part of FHIR.

Explanation of the columns that may appear on this page:

Lvl A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information
Source The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code